Briefcases -- Drugs -- ONGLYZA (saxagliptin) and KOMBIGLYZE XR (saxagliptin and metformin) MDL 2809 USDC ED Kentucky

ONGLYZA (saxagliptin) and KOMBIGLYZE XR (saxagliptin and metformin) MDL 2809 USDC ED Kentucky

Case Files
News
Committees
Request a Document
Request
Search Within Briefcase

Folders

  1. JPML Initial Transfer and Consolidation Order
  2. Initial Case Filing Templates
    1. Plaintiff Fact Sheet(s)
    2. Defendant Fact Sheet(s)
  3. Court Orders
    1. Case Management Orders (CMOs)
    2. Leadership Committee and Appointments
    3. Discovery and Protective Orders
  4. Evidentiary and Research Documents
    1. FDA Regulatory Materials

Quick Access

  1. ONGLYZA (saxagliptin) and KOMBIGLYZE XR (saxagliptin and metformin) MDL 2809 JPML Initial Transfer Order (February 2, 2018)
  2. ONGLYZA and KOMBIGLYZE XR MDL 2809 Case Management Order (CMO) No. 2 Profile Forms and Fact Sheet Protocols (January 9, 2019)
  3. ONGLYZA (saxagliptin) and KOMBIGLYZE XR (saxagliptin and metformin) MDL 2809 Order Appointing Plaintiffs' Leadership Structure (September 6, 2018)
  4. ONGLYZA (saxagliptin) and KOMBIGLYZE XR (saxagliptin and metformin) MDL 2809 Order Appointing Plaintiffs' Leadership Structure (September 6, 2018)
  5. ONGLYZA and KOMBIGLYZE XR MDL 2809 Case Management Order (CMO) No. 1 re General Causation (October 24, 2018)
  6. ONGLYZA (saxagliptin) and KOMBIGLYZE XR (saxagliptin and metformin) MDL 2809 USDC ED Kentucky Electronic Filing Attorney Registration Form
  7. ONGLYZA and KOMBIGLYZE XR MDL 2809 Case Management Order (CMO) No. 2 Profile Forms and Fact Sheet Protocols (January 9, 2019)
  8. ONGLYZA (saxagliptin) and KOMBIGLYZE XR (saxagliptin and metformin) MDL 2809 Order Appointing Plaintiffs' Leadership Structure (September 6, 2018)